Menu

/

King’s College London proud to be part of GliMR

March 4, 2021

Share:

In a recent interview, Dr. Thomas Booth explained the need for more research on advanced MRI for glioma diagnosis. Read the interview here.

Thomas is one of the UK representatives and affiliated with the School of Biomedical Engineering & Imaging Sciences, King’s College London. He was involved in the publication of the GliMR Presentation Paper and is the lead of review 2: ‘MR Biomarkers for assessing the treatment follow-up’, which is currently in development.

Recent News

The future of GliMR

October 15, 2024

A letter from our Chair Dear GliMR Member, We are very happy that we are now able to structure our GliMR working group of the ESMRMB. It is a time of transition for us as GliMR, where we are...

A guide to advanced MRI processing

April 27, 2024

PREPRINT AND POSTER ARE OUT NOW

GliMR2.0 continues... as a working group of ESMRMB

April 3, 2024

SUBMIT YOUR ABSTRACT NOW!

COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

COST Action CA18206

This COST Action aims to build a pan-European and multidisciplinary network of international experts in glioma research, patient organisations, data scientists, and MR imaging scientists by uniting the glioma imaging community within Europe and progressing the development and application of advanced MR imaging for improved decision making in diagnosis, patient monitoring, and assessment of treatment response in clinical trials and clinical practice.

Action Details

Memorandum of Understanding (MoU)
Start Date: 12 September 2019
End Date: 11 September 2023
CSO approval date: 4 June 2019
Email: glimrca18206@erasmusmc.nl

Subscribe Newsletter

By subscribing you agree with our Privacy Policy.

Design by Boutik